Hyperbaric oxygen therapy in idiopathic sudden sensorineural hearing loss (ISSNHL) in association with combined treatment
- PMID: 21510273
Hyperbaric oxygen therapy in idiopathic sudden sensorineural hearing loss (ISSNHL) in association with combined treatment
Abstract
The main basic effect of hyperbaric oxygenation (HBO2) on the human body, in our study, was an increased partial pressure of oxygen resulting from an increased amount of oxygen dissolved in plasma. Thus the plasma can become capable of carrying enough oxygen to meet the needs of the body's tissues. From 1 January 2004 to 31 December 2007, a total of 61 patients (62 ears) received medical treatment at the ENT clinic of the 3rd Faculty of Medicine, Charles University, and at the Central Military Hospital in Prague. Treatment consisted of a combination of vasodilatation infusion treatment and HBO2 therapy. The results were evaluated in a retrospective study. The overall percentage of patients showing improvement was 59.7%. However, for those patients who started HBO2 treatment within 10 days of onset, complete recovery, or significant improvement was noted in 65.9%. In contrast, patients who started treatment after 10 days of onset, improvement was noted in only 38.9%. NMR examination revealed that two patients had vestibular schwannoma (also known as acoustic neuroma).
Similar articles
-
Hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss.Undersea Hyperb Med. 2012 May-Jun;39(3):777-92. Undersea Hyperb Med. 2012. PMID: 22670557 Review.
-
[Effectiveness of pharmacologic therapy combined with hyperbaric oxygen in sensorineural hearing loss following acute acoustic trauma. Preliminary report].Pol Merkur Lekarski. 2005 Sep;19(111):348-50. Pol Merkur Lekarski. 2005. PMID: 16358866 Polish.
-
Hyperbaric oxygen therapy with short duration intratympanic steroid therapy for sudden hearing loss.Acta Otolaryngol. 2012 May;132(5):475-81. doi: 10.3109/00016489.2011.647360. Epub 2012 Jan 31. Acta Otolaryngol. 2012. PMID: 22292673 Clinical Trial.
-
Efficacy of intratympanic steroid administration on idiopathic sudden sensorineural hearing loss in comparison with hyperbaric oxygen therapy.Laryngoscope. 2012 May;122(5):1154-7. doi: 10.1002/lary.23245. Epub 2012 Mar 23. Laryngoscope. 2012. PMID: 22447636
-
Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.Laryngoscope. 2007 Jan;117(1):3-15. doi: 10.1097/01.mlg.0000245058.11866.15. Laryngoscope. 2007. PMID: 17202923 Review.
Cited by
-
Lassa fever: the challenges of curtailing a deadly disease.Pan Afr Med J. 2012;11:55. Epub 2012 Mar 23. Pan Afr Med J. 2012. PMID: 22593791 Free PMC article.
-
Audiometric Evaluation of the Relationship between Sensorineural Hearing Loss and Chronic Glaucoma.Turk J Ophthalmol. 2023 Apr 20;53(2):105-110. doi: 10.4274/tjo.galenos.2022.66990. Turk J Ophthalmol. 2023. PMID: 37089021 Free PMC article.
-
Treatment of sudden sensorineural hearing loss with tinnitus with Fu subcutaneous needling: A case report.Medicine (Baltimore). 2024 Dec 20;103(51):e41100. doi: 10.1097/MD.0000000000041100. Medicine (Baltimore). 2024. PMID: 39705415 Free PMC article.
-
Successful treatment of sudden sensorineural hearing loss by means of pharmacotherapy combined with early hyperbaric oxygen therapy: Case report.Medicine (Baltimore). 2017 Dec;96(51):e9397. doi: 10.1097/MD.0000000000009397. Medicine (Baltimore). 2017. PMID: 29390550 Free PMC article.
-
The use of hyperbaric oxygen therapy in acute hearing loss: a narrative review.Eur Arch Otorhinolaryngol. 2019 Jul;276(7):1859-1880. doi: 10.1007/s00405-019-05469-7. Epub 2019 May 20. Eur Arch Otorhinolaryngol. 2019. PMID: 31111252 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous